Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: The GenePD study

Neurology

Volumn 67, Issue 12, 2006, Pages 2206-2210

  Wilk, J B ^a   Tobin, J E ^a   Suchowersky, O ^c   Shill, H A ^d   Klein, C ^e   Wooten, G F ^f   Lew, M F ^g   Mark, M H ^h   Guttman, M ⁱ   Watts, R L ^j   Singer, C ^k   Growdon, J H ^l   Latourelle, J C ^a   Saint Hilaire, M H ^a   DeStefano, A L ^a,b   Prakash, R ^a   Williamson, S ^a   Berg, C J ^a   Sun, M ^l   Goldwurm, S ^m   Pezzoli, G ^m   Racette, B A ⁿ   Perlmutter, J S ⁿ   Parsian, A ^o   Baker, K B ^p   Giroux, M L ^p   Litvan, I ^q   Pramstaller, P P ^r   Nicholson, G ^s   Burn, D J ^t   Chinnery, P F ^t   Vieregge, P ^u   Slevin, J T ^v,w   Cambi, F ^v   MacDonald, M E ^l   Gusella, J F ^l   Myers, R H ^a   Golbe, L I ^h   more..

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d Muhammad Ali Parkinson Res Center   (United States)

^e UNIVERSITY OF LÜBECK   (Germany)

^f UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j The University of Alabama at Birmingham   (United States)

^k UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

^m PARKINSON INSTITUTE   (Italy)

ⁿ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^p LERNER RESEARCH INSTITUTE   (United States)

^q University of Louisville School of Medicine   (United States)

^r CENTRAL HOSPITAL OF BOLZANO   (Italy)

^s UNIVERSITY OF SYDNEY   (Australia)

^t NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^u KLINIKUM LIPPE DETMOLD   (Germany)

^v UNIVERSITY OF KENTUCKY   (United States)

^w LEXINGTON VA MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOMESTIC CHEMICAL; GLUTATHIONE TRANSFERASE P1; HERBICIDE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME MODIFICATION; FAMILIAL DISEASE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OCCUPATIONAL EXPOSURE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TOXICOGENETICS;

DISEASE SUSCEPTIBILITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE S-TRANSFERASE PI; HAPLOTYPES; HERBICIDES; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PARKINSON DISEASE, SECONDARY; RISK ASSESSMENT; RISK FACTORS;

EID: 33845948124     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000249149.22407.d1     Document Type: Article

References (25)

1. Hubble JP, Cao T, Hassanein RE, Neuberger JS, Koller WC. Risk factors for Parkinson's disease. Neurology 1993;43:1693-1697.
2. Seidler A, Hellenbrand W, Robra BP, et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 1996;46:1275-1284.
3. Semchuk KM, Love EJ, Lee RG. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 1993;43:1173-1180.
4. Koller W, Vetere-Overfield B, Gray C, et al. Environmental risk factors in Parkinson's disease. Neurology 1990;40:1218-1221.
5. Tanner CM, Ottman R, Goldman SM, et al. Parkinson disease in twins: an etiologic study. JAMA 1999;281:341-346.
6. Taylor CA, Saint-Hilaire MH, Cupples LA, et al. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. Am J Med Genet 1999;88:742-749.
7. Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS. Pesticides and Parkinson's disease: is there a link? Environ Health Perspect 2006;114:156-164.
8. Ascherio A, Chen H, Weisskopf MG, et al. Pesticide exposure and risk for Parkinson's disease. Ann Neurol 2006;60:197-203.
9. Di Ilio C, Sacchetta P, Iannarelli V, Aceto A. Binding of pesticides to alpha, mu and pi class glutathione transferase. Toxicol Lett 1995;76:173-177.
10. Zimniak P, Nanduri B, Pikula S, et al. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 1994;224:893-899.
11. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998;352:1344-1346.
12. Kelada SN, Stapleton PL, Farin FM, et al. Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease. Neurosci Lett 2003;337:5-8.
13. Deng Y, Newman B, Dunne MP, Silburn PA, Mellick GD. Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease. Neurosci Lett 2004;366:326-331.
14. DeStefano AL, Golbe LI, Mark MH, et al. Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology 2001;57:1124-1126.
15. Maher NE, Golbe LI, Lazzarini AM, et al. Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology 2002;58:79-84.
16. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
17. Karamohamed S, Golbe LI, Mark MH, et al. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Mov Disord 2005;20:1188-1191.
18. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-434.
19. Schaid DJ. Relative efficiency of ambiguous vs. directly measured haplotype frequencies. Genet Epidemiol 2002;23:426-443.
20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
21. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229.
22. Nicodemus KK, Liu W, Chase GA, Tsai YY, Fallin MD. Comparison of type I error for multiple test corrections in large single-nucleotide polymorphism studies using principal components versus haplotype blocking algorithms. BMC Genet 2005;6 (suppl 1):S78.
23. di Ilio C, Sacchetta P, Angelucci S, et al. Interaction of glutathione transferase P1-1 with captan and captafol. Biochem Pharmacol 1996;52:43-48.
24. Abel EL, Opp SM, Verlinde CL, Bammler TK, Eaton DL. Characterization of atrazine biotransformation by human and murine glutathione S-transferases. Toxicol Sci 2004;80:230-238.
25. Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 1997;324(pt 1):25-28.